Navigation Links
Treatment Available for Macular Degeneration Low Vision in Connecticut

DANBURY, Conn., April 23, 2013 /PRNewswire-iReach/ -- Prismatic Magnifying Readers (PMRs) can often help people with macular degeneration, glaucoma, diabetic retinopathy and others with low vision who are having difficulty reading by providing extra magnification and comfort.  The most common vision loss for someone with low vision is the reduced ability to read.

Dr. Randolph Kinkade , a Connecticut optometrist and founding member of the International Academy of Low Vision Specialists, has coined the new term Prismatic Magnifying Readers to describe the design and purpose behind these beneficial low vision glasses.

Prismatic Magnifying Readers, when combined with enhanced illumination, often improve reading ability.  Individuals whose vision is in the range of 20/50 to 20/200 and is relatively equal in both eyes can benefit from PMRs.

"The prism enables material to be held at a closer reading distance allowing for more magnification and comfort", said Dr. Kinkade.  "The prism improves binocular viewing which in turn improves the reading field of view.  Words are not only larger, but more words can be seen at a time."

Holding reading material close (closer than 16") creates the magnification.  The closer the reading material is held to the eyes the more the focusing magnification can be created by the glasses.  For example, when reading material is held at 8" from the eyes 2X magnification is created compared to when the same material was held at 16" (a normal reading distance).  When the material is held at 4" from the eyes 4X magnification is generated.  Bigger is better for people with low vision.

Lens strength is usually measured in the optical term "diopters" which is different than "magnification power".   The more diopters in the prescription the closer the reading material must be held to the eyes.

"The prism is designed to reduce binocular eye fatigue and reading stress", said Dr. Kinkade.  "The closer the book is held to the eyes, the more the eyes must turn in for binocular viewing.  Without prism, there is a limit to how much the eyes can naturally and comfortably turn in."

There are also limits to the amount of prism that can be beneficial in a prescription.  Twelve units of prism in each eye is often the practical limit.   At a 4" viewing distance patients may be better off reading with one eye; the best eye.  At this point the prescription is changed from PMRs to monocular microscopic glasses (very high power for one eye only).

Pictures of Prismatic Magnifying Readers, educational videos, and television interviews are available at

Dr. Kinkade has offices throughout Connecticut.  He can be contacted at (800) 756-0766 and at

About Macular Degeneration

Macular degeneration is usually an age-related eye disease that can result in considerable vision loss. It occurs when the macula, or center part of the retina providing 20/20 vision, begins to breakdown.

The macula is an extremely important part of the retina used for seeing. It allows us to focus and carry out many vision related duties like reading, writing, driving and crafts. The macula is essential for crisp detail vision.

Dry macular degeneration is considered the most common (80-90%) and consists of yellow deposits (drusen) developing in the macula. In dry macular degeneration, blind spots develop within the line of vision. The decrease in vision is usually gradual and takes many years to develop. There is not effective treatment for this form of the disease.

Wet macular degeneration is more prone to rapid and severe vision loss if not treated. In this condition blood vessels develop and leak fluid behind the macula. Current treatment involves a series of injections to stop the vessels from developing.

Media Contact:

Randolph Kinkade , OD, MPH Low Vision Consulting, (800) 756-0766,

News distributed by PR Newswire iReach:

SOURCE Low Vision Consulting
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. For Treatment of Extensive-Disease Small-Cell Lung Cancer (ED-SCLC), No Emerging Therapy is Likely to Replace Etoposide/Carboplatin as the Standard of Care Before 2022
2. Cancer Experts Detail Advanced Radiosurgery Treatments for Lung Cancer Using Varian Medical Systems Technologies
3. Significant Unmet Medical Need for Treatment of Patients with Chronic Pain with Dysphagia (CPD)
4. Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection
5. Results of Pediatric Clinical Trial of External Trigeminal Nerve Stimulation for the Treatment of ADHD
6. Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients
7. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
8. ARMGO Pharma Receives $1 Million Award from MDA to Support Advancement of Rycal Compound ARM210 as a Novel Treatment for Duchenne Muscular Dystrophy
9. FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
10. Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems
11. Electrical pulse treatment pokes holes in hard-to-treat tumors
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 ... addition of the  "Global Drug Device ... to their offering.  --> ... of the  "Global Drug Device Combination ... their offering.  --> Research ...
(Date:11/24/2015)... 2015 WuXi PharmaTech (Cayman) Inc. ("WuXi" or ... R&D capability and technology platform company serving the pharmaceutical, ... China and the United ... general meeting of shareholders held today, the Company,s shareholders ... approve the previously announced agreement and plan of merger ...
(Date:11/24/2015)... CARLOS, Calif. , Nov. 24, 2015 ... a leader in non-invasive genetic testing and ... announced that it will present at the ... in New York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew ... the Company,s financial results, business activities and ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has focused on providing comprehensive solutions involving adult stem cell therapies to patients ... officially deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
(Date:11/24/2015)... ... November 24, 2015 , ... New patients who wish ... referral for dental implants at her Mississauga, ON practice. Dr. Williams has ... the placement of dental implants. , Missing teeth can lead to a variety ...
(Date:11/24/2015)... FRANCISCO, CA (PRWEB) , ... November 24, 2015 ... ... half-cup sizes, has launched their Black Friday sale a week early, offering 40% ... continues to transform the intimate apparel industry through both mobile fit technology and ...
(Date:11/24/2015)... ... November 24, 2015 , ... DMG Productions announced that they will feature ... quarter 2016 via Discovery Channel. Dates and show times TBA. , Aphria, Inc., is ... the business of producing and supplying medical marijuana pursuant to the Marijuana for Medical ...
Breaking Medicine News(10 mins):